T 1627/18 (Liposomes with lipids having an advantageous pKa-value for RNA delivery / GLAXOSMITHKLINE) of 16.12.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T162718.20201216
- Date of decision
- 16 December 2020
- Case number
- T 1627/18
- Petition for review of
- -
- Application number
- 11736500.7
- IPC class
- A61K 39/00C12N 15/86A61K 9/127
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- Dennemeyer & Associates S.A.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a) (2007)European Patent Convention Art 54(2) (2007)European Patent Convention R 84(2) (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)
- Keywords
- Novelty - main request (yes)
Remittal - special reasons for remittal - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0606/22
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.